Basic fibroblast growth factor upregulates cyclooxygenase-2 in I407 cells through p38 MAP kinase

Teresa G. Tessner, Filipe Muhale, Suzanne Schloemann, Steven Cohn, Aubrey Morrison, William F. Stenson

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The intestinal cell line I407 responds to basic fibroblast growth factor (bFGF) by upregulating cyclooxygenase-2 (COX-2) mRNA and protein expression and increasing PGE2 production. bFGF treatment of I407 cells results in phosphorylation of p38, and the p38 inhibitor SB-203580 abrogates bFGF-induced PGE2 synthesis. Wild-type p38α (p38αWT) and dominant-negative p38α (p38αDN) stable transfectant clones of I407 cells were used to examine the role of the p38 MAP kinase pathway in the events controlling PGE2 synthesis after treatment with bFGF. Treatment of p38αWT clones with bFGF resulted in increased COX-2 protein levels and PGE2 synthesis similar to those seen in bFGF-treated control-transfected cells. In contrast, the p38αDN clones failed to upregulate COX-2 protein or increase PGE2 synthesis when treated with bFGF. Exogenous arachidonate did not restore PGE2 synthesis by p38αDN cells. bFGF treatment increased COX-2 mRNA stability, and the p38 inhibitor SB-203580 attenuated COX-2 mRNA stability in bFGF-treated I407 cells. These data demonstrate a crucial role for p38a in growth factor-induced PGE2 synthesis by intestinal cells. Furthermore, they indicate that p38 activity is required at a step distal to arachidonate release, most likely COX-2 upregulation, because exogenous arachidonate did not restore PGE2 synthesis.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Gastrointestinal and Liver Physiology
Volume284
Issue number2 47-2
StatePublished - Feb 1 2003
Externally publishedYes

Fingerprint

p38 Mitogen-Activated Protein Kinases
Fibroblast Growth Factor 2
Cyclooxygenase 2
Dinoprostone
Up-Regulation
Clone Cells
RNA Stability
Proteins
MAP Kinase Signaling System
Intercellular Signaling Peptides and Proteins
Phosphorylation
Cell Line
Messenger RNA

Keywords

  • Arachidonic acid metabolism
  • Intestinal epithelial cells
  • Intestinal injury and repair
  • mRNA stability

ASJC Scopus subject areas

  • Gastroenterology
  • Physiology

Cite this

Basic fibroblast growth factor upregulates cyclooxygenase-2 in I407 cells through p38 MAP kinase. / Tessner, Teresa G.; Muhale, Filipe; Schloemann, Suzanne; Cohn, Steven; Morrison, Aubrey; Stenson, William F.

In: American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 284, No. 2 47-2, 01.02.2003.

Research output: Contribution to journalArticle

Tessner, Teresa G. ; Muhale, Filipe ; Schloemann, Suzanne ; Cohn, Steven ; Morrison, Aubrey ; Stenson, William F. / Basic fibroblast growth factor upregulates cyclooxygenase-2 in I407 cells through p38 MAP kinase. In: American Journal of Physiology - Gastrointestinal and Liver Physiology. 2003 ; Vol. 284, No. 2 47-2.
@article{8267ac16be954df79aae652c82e1a70a,
title = "Basic fibroblast growth factor upregulates cyclooxygenase-2 in I407 cells through p38 MAP kinase",
abstract = "The intestinal cell line I407 responds to basic fibroblast growth factor (bFGF) by upregulating cyclooxygenase-2 (COX-2) mRNA and protein expression and increasing PGE2 production. bFGF treatment of I407 cells results in phosphorylation of p38, and the p38 inhibitor SB-203580 abrogates bFGF-induced PGE2 synthesis. Wild-type p38α (p38αWT) and dominant-negative p38α (p38αDN) stable transfectant clones of I407 cells were used to examine the role of the p38 MAP kinase pathway in the events controlling PGE2 synthesis after treatment with bFGF. Treatment of p38αWT clones with bFGF resulted in increased COX-2 protein levels and PGE2 synthesis similar to those seen in bFGF-treated control-transfected cells. In contrast, the p38αDN clones failed to upregulate COX-2 protein or increase PGE2 synthesis when treated with bFGF. Exogenous arachidonate did not restore PGE2 synthesis by p38αDN cells. bFGF treatment increased COX-2 mRNA stability, and the p38 inhibitor SB-203580 attenuated COX-2 mRNA stability in bFGF-treated I407 cells. These data demonstrate a crucial role for p38a in growth factor-induced PGE2 synthesis by intestinal cells. Furthermore, they indicate that p38 activity is required at a step distal to arachidonate release, most likely COX-2 upregulation, because exogenous arachidonate did not restore PGE2 synthesis.",
keywords = "Arachidonic acid metabolism, Intestinal epithelial cells, Intestinal injury and repair, mRNA stability",
author = "Tessner, {Teresa G.} and Filipe Muhale and Suzanne Schloemann and Steven Cohn and Aubrey Morrison and Stenson, {William F.}",
year = "2003",
month = "2",
day = "1",
language = "English (US)",
volume = "284",
journal = "American Journal of Physiology - Endocrinology and Metabolism",
issn = "0193-1849",
publisher = "American Physiological Society",
number = "2 47-2",

}

TY - JOUR

T1 - Basic fibroblast growth factor upregulates cyclooxygenase-2 in I407 cells through p38 MAP kinase

AU - Tessner, Teresa G.

AU - Muhale, Filipe

AU - Schloemann, Suzanne

AU - Cohn, Steven

AU - Morrison, Aubrey

AU - Stenson, William F.

PY - 2003/2/1

Y1 - 2003/2/1

N2 - The intestinal cell line I407 responds to basic fibroblast growth factor (bFGF) by upregulating cyclooxygenase-2 (COX-2) mRNA and protein expression and increasing PGE2 production. bFGF treatment of I407 cells results in phosphorylation of p38, and the p38 inhibitor SB-203580 abrogates bFGF-induced PGE2 synthesis. Wild-type p38α (p38αWT) and dominant-negative p38α (p38αDN) stable transfectant clones of I407 cells were used to examine the role of the p38 MAP kinase pathway in the events controlling PGE2 synthesis after treatment with bFGF. Treatment of p38αWT clones with bFGF resulted in increased COX-2 protein levels and PGE2 synthesis similar to those seen in bFGF-treated control-transfected cells. In contrast, the p38αDN clones failed to upregulate COX-2 protein or increase PGE2 synthesis when treated with bFGF. Exogenous arachidonate did not restore PGE2 synthesis by p38αDN cells. bFGF treatment increased COX-2 mRNA stability, and the p38 inhibitor SB-203580 attenuated COX-2 mRNA stability in bFGF-treated I407 cells. These data demonstrate a crucial role for p38a in growth factor-induced PGE2 synthesis by intestinal cells. Furthermore, they indicate that p38 activity is required at a step distal to arachidonate release, most likely COX-2 upregulation, because exogenous arachidonate did not restore PGE2 synthesis.

AB - The intestinal cell line I407 responds to basic fibroblast growth factor (bFGF) by upregulating cyclooxygenase-2 (COX-2) mRNA and protein expression and increasing PGE2 production. bFGF treatment of I407 cells results in phosphorylation of p38, and the p38 inhibitor SB-203580 abrogates bFGF-induced PGE2 synthesis. Wild-type p38α (p38αWT) and dominant-negative p38α (p38αDN) stable transfectant clones of I407 cells were used to examine the role of the p38 MAP kinase pathway in the events controlling PGE2 synthesis after treatment with bFGF. Treatment of p38αWT clones with bFGF resulted in increased COX-2 protein levels and PGE2 synthesis similar to those seen in bFGF-treated control-transfected cells. In contrast, the p38αDN clones failed to upregulate COX-2 protein or increase PGE2 synthesis when treated with bFGF. Exogenous arachidonate did not restore PGE2 synthesis by p38αDN cells. bFGF treatment increased COX-2 mRNA stability, and the p38 inhibitor SB-203580 attenuated COX-2 mRNA stability in bFGF-treated I407 cells. These data demonstrate a crucial role for p38a in growth factor-induced PGE2 synthesis by intestinal cells. Furthermore, they indicate that p38 activity is required at a step distal to arachidonate release, most likely COX-2 upregulation, because exogenous arachidonate did not restore PGE2 synthesis.

KW - Arachidonic acid metabolism

KW - Intestinal epithelial cells

KW - Intestinal injury and repair

KW - mRNA stability

UR - http://www.scopus.com/inward/record.url?scp=0037304236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037304236&partnerID=8YFLogxK

M3 - Article

VL - 284

JO - American Journal of Physiology - Endocrinology and Metabolism

JF - American Journal of Physiology - Endocrinology and Metabolism

SN - 0193-1849

IS - 2 47-2

ER -